Experimental drug auxora shows promise in severe COVID-19 pneumonia trial
NCT ID NCT04345614
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called Auxora in 314 people with severe COVID-19 pneumonia. The goal was to see if it could help patients recover faster and reduce the need for breathing machines. Participants received either Auxora or a placebo, along with standard treatments. Results focused on recovery time and survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aurora Baycare
Green Bay, Wisconsin, 54311, United States
-
Baton Rouge General
Baton Rouge, Louisiana, 70809, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
John Peter Smith Hospital
Fort Worth, Texas, 76104, United States
-
Long Beach Memorial
Long Beach, California, 90806, United States
-
Maine Medical Center
Portland, Maine, 04102, United States
-
Methodist Hospital
Saint Louis Park, Minnesota, 55426, United States
-
National Jewish Health / St. Joseph's Hospital
Denver, Colorado, 80220, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Regions Hospital
Saint Paul, Minnesota, 55101, United States
-
Sharp Memorial San Diego
San Diego, California, 92123, United States
-
Sinai Grace
Detroit, Michigan, 48235, United States
-
Texas Tech University Medical Center
El Paso, Texas, 79905, United States
-
University of Southern California / LA County
Los Angeles, California, 90033, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Breathing technique may outperform spirometry for smog pneumonia recovery
- A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
- Can a smart oxygen device shorten hospital stays for pneumonia?
- Could everyday supplements shield your lungs?
- Can a simple inhaled combo keep pneumonia patients off ventilators?